Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group.
Jamie M AyeWei XueJoshua David PalmerDavid O WalterhouseMichael A ArnoldTodd E HeatonRajkumar VenkatramaniPublished in: Pediatric blood & cancer (2021)
Patients with localized biliary RMS treated on low-risk studies had suboptimal outcomes. These patients may benefit from therapy on intermediate-risk studies.